rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Sukhi Jagpal

Director

Company insider

Files Form 4 as: Director, Sutro Biopharma; Chief Financial Officer, Sierra Oncology; Chief Financial Officer, Qlt Inc/bc.

Every Form 4 they filed

In numbers

Trades disclosed
42
Buys
0
Sells
2
Bought
$0
Sold
$628K
Companies
3
Companies where not an officer
1
First trade
3 Aug 2012
Last trade
5 Jun 2026
Last filed
9 Jun 2026

Companies traded

Where they are an officer
Sierra OncologyOfficer · last 1 Jul 20220 buys · 0 sells
Qlt Inc/bcOfficer · last 15 Jul 20130 buys · 2 sells
Everywhere else they filed: board seats, 10% stakes, other companies
STRO Sutro BiopharmaDirector · Biotechnology · last 5 Jun 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
5 Jun 2026filed 9 Jun 2026STRO Sutro Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
5 Jun 2026filed 9 Jun 2026STRO Sutro Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
23 Dec 2025filed 29 Dec 2025STRO Sutro Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—1,500 at $0.00filing
6 Jun 2025filed 10 Jun 2025STRO Sutro Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
8 Aug 2024filed 12 Aug 2024STRO Sutro Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—35,000 at $0.00filing
8 Aug 2024filed 12 Aug 2024STRO Sutro Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—28,959 at $0.00filing
1 Jul 2022filed 1 Jul 2022Sierra Oncologyoption or derivativeSEC FORM 4 Code D—3,859 at $0.00filing
1 Jul 2022filed 1 Jul 2022Sierra Oncologyoption or derivativeSEC FORM 4 Code D—1,218 at $0.00filing
1 Jul 2022filed 1 Jul 2022Sierra Oncologyoption or derivativeSEC FORM 4 Code D—4,200 at $0.00filing
1 Jul 2022filed 1 Jul 2022Sierra Oncologyoption or derivativeSEC FORM 4 Code D—1,750 at $0.00filing
1 Jul 2022filed 1 Jul 2022Sierra Oncologyoption or derivativeSEC FORM 4 Code D—4,509 at $0.00filing
1 Jul 2022filed 1 Jul 2022Sierra Oncologyoption or derivativeSEC FORM 4 Code D—5,000 at $0.00filing
1 Jul 2022filed 1 Jul 2022Sierra Oncologyoption or derivativeSEC FORM 4 Code D—94,113 at $0.00filing
1 Jul 2022filed 1 Jul 2022Sierra Oncologyoption or derivativeSEC FORM 4 Code D—49,000 at $0.00filing
1 Jul 2022filed 1 Jul 2022Sierra Oncologyoption or derivativeSEC FORM 4 Code D—5,887 at $0.00filing
1 Jul 2022filed 1 Jul 2022Sierra Oncologyoption or derivativeSEC FORM 4 Code D—30,000 at $0.00filing
1 Jul 2022filed 1 Jul 2022Sierra Oncologyoption or derivativeSEC FORM 4 Code D—50,000 at $0.00filing
17 Jun 2022filed 17 Jun 2022Sierra Oncologyoption or derivativeSEC FORM 4 Code A—12,250 at $0.00filing
14 Mar 2022filed 14 Mar 2022Sierra Oncologyoption or derivativeSEC FORM 4 Code A—50,000 at $0.00filing
28 Jan 2022filed 28 Jan 2022Sierra Oncologyoption or derivativeSEC FORM 4 Code A—12,250 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed2

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.